Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Christopher Domen to Humans

This is a "connection" page, showing publications Christopher Domen has written about Humans.

 
Connection Strength
 
 
 
0.100
 
  1. Domen CH, Sillau S, Liu Y, Leehey MA. Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds. Mov Disord. 2024 Jan; 39(1):222-223.
    View in: PubMed
    Score: 0.021
  2. Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA. Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and ?9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms. Mov Disord. 2023 07; 38(7):1341-1346.
    View in: PubMed
    Score: 0.021
  3. Domen CH, Greher MR, Hosokawa PW, Barnes SL, Hoyt BD, Wodushek TR. Are Established Embedded Performance Validity Test Cut-Offs Generalizable to Patients With Multiple Sclerosis? Arch Clin Neuropsychol. 2020 Jul 24; 35(5):511-516.
    View in: PubMed
    Score: 0.017
  4. Domen CH, Collins RL, Davis JJ. The APPCN multisite didactic initiative: Development, benefits, and challenges. Clin Neuropsychol. 2021 01; 35(1):115-132.
    View in: PubMed
    Score: 0.017
  5. Wodushek TR, Domen CH. Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery. Appl Neuropsychol Adult. 2020 Jan-Feb; 27(1):9-21.
    View in: PubMed
    Score: 0.015
  6. Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA. Short-Term Cannabidiol with ?-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Mov Disord. 2024 May; 39(5):863-875.
    View in: PubMed
    Score: 0.005
  7. Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. Mult Scler Relat Disord. 2019 Jan; 27:383-390.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)